<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Advaxis, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Advaxis, Inc.

    Advaxis was founded on the vision that no one should suffer from the burdens of cancer. Our goal is to develop cancer immunotherapies that teach the body to recognize tumors as a threat and do so in a way that minimizes side effects associated with traditional chemotherapy and radiation. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Kenneth A. Berlin
    • FOUNDED
      2002
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    iRhythm Technologies, Inc.

    iRhythm Technologies, Inc.

    iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are...

    iRhythm is a digital healthcare company redefin...

    Filing Type:    PU
    Gilead Sciences, Inc.

    Gilead Sciences, Inc.

    Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers...

    Gilead Sciences, Inc. is a research-based bioph...

    Filing Type:    PU
    Kodiak Sciences Inc

    Kodiak Sciences Inc

    Kodiak Sciences is a clinical stage company developing innovative therapeutics to ...

    Kodiak Sciences is a clinical stage company dev...

    Filing Type:    PU
    ZYPPAH, Inc.

    ZYPPAH, Inc.

    Stop the root cause of snoring by going directly after the tongue. ZYPPAH is the o...

    Stop the root cause of snoring by going directl...

    Amount Raised:    $359,340.00
    Fundraising Status:    EC
    Filing Type:    CF
    Five Prime Therapeutics, Inc.

    Five Prime Therapeutics, Inc.

    Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to im...

    Five Prime Therapeutics, Inc. discovers and dev...

    Filing Type:    PU
    PolarityTE, Inc.

    PolarityTE, Inc.

    PolarityTE is a commercial-stage biotechnology and regenerative biomaterials compa...

    PolarityTE is a commercial-stage biotechnology ...

    Filing Type:    PU
    Progenics Pharmaceuticals Inc.

    Progenics Pharmaceuticals Inc.

    Progenics develops innovative medicines and other technologies to target and treat...

    Progenics develops innovative medicines and oth...

    Filing Type:    PU
    Novavax, Inc.

    Novavax, Inc.

    Novavax, Inc. is a clinical-stage vaccine company committed to delivering novel pr...

    Novavax, Inc. is a clinical-stage vaccine compa...

    Filing Type:    PU
    Blueprint Medicines Corporation

    Blueprint Medicines Corporation

    Blueprint Medicines is a precision therapy company striving to improve human healt...

    Blueprint Medicines is a precision therapy comp...

    Filing Type:    PU
    Halozyme Therapeutics, Inc.

    Halozyme Therapeutics, Inc.

    Halozyme is a clinical-stage biotechnology company focused on developing and comme...

    Halozyme is a clinical-stage biotechnology comp...

    Filing Type:    PU
    Fate Therapeutics, Inc.

    Fate Therapeutics, Inc.

    We are a biopharmaceutical company dedicated to the development of programmed cell...

    We are a biopharmaceutical company dedicated to...

    Filing Type:    PU
    argenx SE

    argenx SE

    argenx is a clinical-stage biotechnology company developing a deep pipeline of dif...

    argenx is a clinical-stage biotechnology compan...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.